Total Assets for ResMed (RMD)
According to ResMed's latest reported financial statements, the company's latest reported total assets is $8.50B USD. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and net assets for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
RMD
Currently viewingTotal AssetsSwitch metric
Latest period
$8.50B
YoY change
+18.9%
5Y CAGR
+12.2%
Peak year (2025)
$8.17B
Latest annual
$8.17B
Total Assets history chart for ResMed (RMD) from 1993 to 2025
Total Assets history table for ResMed (RMD) from 1993 to 2025
| Fiscal year | Period ended | Reported | Total Assets | YoY |
|---|---|---|---|---|
| 2025 | $8.17B | +18.9% | ||
| 2024 | $6.87B | +1.8% | ||
| 2023 | $6.75B | +32.5% | ||
| 2022 | $5.10B | +7.8% | ||
| 2021 | $4.73B | +3.1% | ||
| 2020 | $4.59B | +11.7% | ||
| 2019 | $4.11B | +34.1% | ||
| 2018 | $3.06B | -11.7% | ||
| 2017 | $3.47B | +6.4% | ||
| 2016 | $3.26B | +49.4% | ||
| 2015 | $2.18B | -7.6% | ||
| 2014 | $2.36B | +6.8% | ||
| 2013 | $2.21B | +3.4% | ||
| 2012 | $2.14B | +3.3% | ||
| 2011 | $2.07B | +27.2% | ||
| 2010 | $1.63B | +7.9% | ||
| 2009 | $1.51B | +7.3% | ||
| 2008 | $1.41B | +12.3% | ||
| 2007 | $1.25B | +24.3% | ||
| 2006 | $1.01B | +30.1% | ||
| 2005 | $774.15M | +41.0% | ||
| 2004 | $549.15M | +19.5% | ||
| 2003 | $459.60M | +22.2% | ||
| 2002 | $376.19M | +30.6% | ||
| 2001 | $288.09M | +149.2% | ||
| 2000 | $115.59M | +28.6% | ||
| 1999 | $89.90M | +39.2% | ||
| 1998 | $64.60M | +17.7% | ||
| 1997 | $54.90M | +16.1% | ||
| 1996 | $47.30M | +34.0% | ||
| 1995 | $35.30M | +267.7% | ||
| 1994 | $9.60M | +84.6% | ||
| 1993 | $5.20M | — |
Total Assets values are taken from ResMed's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, ResMed (RMD) total assets totalled $8.17B – grew 18.9% year-over-year.
Across 2020–2025 (5 years), ResMed total assets produced a CAGR of +12.2% – sustaining 7 straight years of year-over-year growth.
The highest annual total assets of $8.17B was reported in 2025. The lowest in the available history was $5.20M in 1993.
Among 8 Healthcare peers, ResMed (RMD) ranks 9th; the peer median for total assets is $135.41B.
ResMed Total Assets by Year
ResMed Total Assets 2025: $8.17B
ResMed total assets in 2025 was $8.17B, grew 18.9% from 2024. This figure represents the highest annual value in the available history.
ResMed Total Assets 2024: $6.87B
ResMed total assets in 2024 was $6.87B, edged up 1.8% from 2023.
ResMed Total Assets 2023: $6.75B
ResMed total assets in 2023 was $6.75B, surged 32.5% from 2022.
ResMed Total Assets 2022: $5.10B
ResMed total assets in 2022 was $5.10B, grew 7.8% from 2021.
ResMed Total Assets 2021: $4.73B
ResMed total assets in 2021 was $4.73B.
See more financial history for ResMed (RMD).
Sector peers — Total Assets
Companies in the same sector as ResMed, ranked by their latest total assets.
| Company | Total Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $542.90B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $309.58B | Healthcare |
| Johnson & Johnson (JNJ) | $199.21B | Healthcare |
| Merck & Co., Inc. (MRK) | $136.87B | Healthcare |
| AbbVie Inc. (ABBV) | $133.96B | Healthcare |
| AstraZeneca PLC (AZN) | $114.07B | Healthcare |
| Eli Lilly and Company (LLY) | $112.48B | Healthcare |
| Amgen Inc. (AMGN) | $90.59B | Healthcare |
Frequently asked questions
What is ResMed's total assets?
- Latest reported total assets for ResMed (RMD) is $8.50B (period ending December 31, 2025).
How has ResMed total assets changed year-over-year?
- ResMed (RMD) total assets changed +18.9% year-over-year on the latest annual filing.
What is the long-term growth rate of ResMed total assets?
- ResMed (RMD) total assets compound annual growth rate is +12.2% over the most recent 5 years available.
When did ResMed total assets hit its highest annual value?
- ResMed total assets reached its highest annual value of $8.17B in 2025.
What was ResMed total assets in 2024?
- ResMed (RMD) total assets in 2024 was $6.87B.
What was ResMed total assets in 2025?
- ResMed (RMD) total assets in 2025 was $8.17B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
RMD Overview
Company profile, financial tools, and key metrics
RMD Revenue Counter
Earns $171.17 every second. See per minute, hour, and day.
RMD Earnings Counter
Earns $47.12 per second net profit. See per minute, hour, and day.
RMD Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
RMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RMD How It Makes Money
Discover visual breakdown of $5.40B in revenue — where it comes from and where it goes.
RMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RMD Daily Price Character
Balanced · 50.4% historical win rate (green days). Streaks & record days.
RMD Buybacks
1.42% TTM buyback yield. Shareholder yield & SBC comparison.
RMD Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
RMD Dividend Profile
Yield: 1.10%. Safety: 6/8. See full history.
RMD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
RMD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.